Patient-reported lower urinary tract symptoms, urinary incontinence, and quality of life after external beam radiotherapy for localized prostate cancer – 15 years’ follow-up. A comparison with age-matched controls

References

• Hanks GE, Martz KL, Diamond JJ. The effect of dose on local control of prostate cancer. Int J Radiat Oncol Biol Phys 1988; 15: 1299–305
   PubMed Web of Science ®Google Scholar
• Zelefsky MJ, Leibel SA, Gaudin PB, Kutcher GJ, Fleshner NE, Venkatramen ES, et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys 1998; 41: 491–500
   PubMed Web of Science ®Google Scholar
• Hanks GE, Hanlon AL, Schultheiss TE, Pinover WH, Movsas B, Epstein BE, et al. Dose escalation with 3D conformal treatment: Five year outcomes, treatment optimization, and future directions. Int J Radiat Oncol Biol Phys 1998; 41: 501–10
   PubMed Web of Science ®Google Scholar
• Pollack A, Zagars GK, Starkschall G, Antolak JA, Lee JJ, Huang E, et al. Prostate cancer radiation dose response: Results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 2002; 53: 1097–105
   PubMed Web of Science ®Google Scholar
• Widmark A, Fransson P, Tavelin B. Self-assessment questionnaire for evaluating urinary and intestinal late side effects after pelvic radiotherapy in patients with prostate cancer compared with an age-matched control population. Cancer 1994; 74: 2520–32
   PubMed Web of Science ®Google Scholar
• Dearnaley DP, Khoo VS, Norman AR, Meyer L, Nahum A, Tait D, et al. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial. Lancet 1999; 353: 267–72
   PubMed Web of Science ®Google Scholar
• Shu HK. Toxicity following high-dose three-dimensional conformal and intensity-modulated radiation therapy for clinically localized prostate cancer. Urology 2001; 57: 102–7
   PubMed Web of Science ®Google Scholar
• Fransson P, Widmark A. Late side effects unchanged 4–8 years after radiotherapy for prostate carcinoma: A comparison with age-matched controls. Cancer 1999; 85: 678–88
   PubMed Web of Science ®Google Scholar
• Fransson P, Tavelin B, Widmark A. Reliability and responsiveness of a prostate cancer questionnaire for radiotherapy-induced side effects. Support Care Cancer 2001; 9: 187–98
   PubMed Web of Science ®Google Scholar
• Hjermstad MJ, Fossa SD, Bjordal K, Kaasa S. Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire. J Clin Oncol 1995; 13: 1249–54
   PubMed Web of Science ®Google Scholar
• Penson DF, Litwin MS, Aaronson NK. Health related quality of life in men with prostate cancer. J Urol 2003; 169: 1653–61
   PubMed Web of Science ®Google Scholar
• McCammon KA, Kolm P, Main B, Schellhammer PF. Comparative quality-of-life analysis after radical prostatectomy or external beam radiation for localized prostate cancer. Urology 1999; 54: 509–16
   PubMed Web of Science ®Google Scholar
• Perez CA, Lee HK, Georgiou A, Lockett MA. Technical factors affecting morbidity in definitive irradiation for localized carcinoma of the prostate. Int J Radiat Oncol Biol Phys 1994; 28: 811–9
   PubMed Web of Science ®Google Scholar
• Shipley WU, Zietman AL, Hanks GE, Coen JJ, Caplan RJ, Won M, et al. Treatment related sequelae following external beam radiation for prostate cancer: A review with an update in patients with stages T1 and T2 tumor. J Urol 1994; 152(5 PT 2)1799–805
   PubMed Web of Science ®Google Scholar
• Jonler M, Ritter MA, Brinkmann R, Messing EM, Rhodes PR, Bruskewitz RC. Sequelae of definitive radiation therapy for prostate cancer localized to the pelvis. Urology 1994; 44: 876–82
   PubMed Web of Science ®Google Scholar
• Vanuytsel L, Ang KK, Vandenbussche L, Vereecken R, van der Schueren E. Radiotherapy in multiple fractions per day for prostatic carcinoma: Late complications. Int J Radiat Oncol Biol Phys 1986; 12: 1589–95
   PubMed Web of Science ®Google Scholar
• Talcott JA, Clark JA, Stark PC, Mitchell SP. Long-term treatment related complications of brachytherapy for early prostate cancer: A survey of patients previously treated. J Urol 2001; 166: 494–9
   PubMed Web of Science ®Google Scholar
• Fowler FJ, Barry MJ, Lu-Yao G, Wasson JH, Bin L. Outcomes of external-beam radiation therapy for prostate cancer: A study of Medicare beneficiaries in three surveillance, epidemiology, and end results areas. J Clin Oncol 1996; 14: 2258–65
   PubMed Web of Science ®Google Scholar
• Ponholzer A, Brössner C, Struhal G, Marszalek M, Madersbacher S. Lower urinary tract symptoms, urinary incontinence, sexual function and quality of life after radical prostatectomy and external beam radiation therapy: Real life experience in Austria. World J Urol 2006; 24: 325–30
   PubMed Web of Science ®Google Scholar
• Adolfsson J, Helgason AR, Dickman P, Steineck G. Urinary and bowel symptoms in men with and without prostate cancer: Results from an observational study in the Stockholm area. Eur Urol 1998; 33: 11–6
   PubMed Web of Science ®Google Scholar
• Schatzl G, Temml C, Schmidbauer J, Dolezal B, Haidinger G, Madersbacher S. Cross-sectional study of nocturia in both sexes: Analysis of a voluntary health screening project. Urology 2000; 56: 71–5
   PubMed Web of Science ®Google Scholar
• Fransson P, Damber JE, Tomic R, Modig H, Nyberg G, Widmark A. Quality of life and symptoms in a randomized trial of radiotherapy versus deferred treatment of localized prostate carcinoma. Cancer 2001; 92: 3111–9
   PubMed Web of Science ®Google Scholar
• Steineck G, Helgesen F, Adolfsson J, Dickman PW, Johansson JE, Norlén BJ, et al. Quality of life after radical prostatectomy or watchful waiting. N Engl J Med 2002; 347: 790–6
   PubMed Web of Science ®Google Scholar